OncoSec Medical Incorporated
ONCSQ
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 18.57% | -9.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.88% | -10.15% | |||
| Operating Income | -4.88% | 10.15% | |||
| Income Before Tax | 14.93% | 1.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.89% | 1.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.89% | 1.89% | |||
| EBIT | -4.88% | 10.15% | |||
| EBITDA | -4.92% | 10.23% | |||
| EPS Basic | 41.11% | 1.92% | |||
| Normalized Basic EPS | 41.14% | 1.92% | |||
| EPS Diluted | 41.11% | 1.92% | |||
| Normalized Diluted EPS | 41.14% | 1.92% | |||
| Average Basic Shares Outstanding | 44.52% | 0.04% | |||
| Average Diluted Shares Outstanding | 44.52% | 0.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||